{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-087248","form_type":"8-K","ticker":"ELOX","cik":"0001035354","company_name":"Eloxx Pharmaceuticals, Inc.","filed_at":"2023-08-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:32.944136+00:00","generated_at":"2026-06-12T06:58:43.284749+00:00","sec_items":["8.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Eloxx receives Nasdaq extension to Oct 9, 2023 to meet $35M market value rule","bullets":["Nasdaq Hearings Panel extended compliance deadline for Listing Rule 5550(b)(2) from July 30 to October 9, 2023.","Company must maintain at least $35 million market value of listed securities to avoid delisting.","Extension follows a May 18, 2023 hearing and a July 27, 2023 request by Eloxx.","Failure to regain compliance by October 9 could result in delisting from Nasdaq Capital Market."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-087248","json":"https://secwatch.observer/filing/0001104659-23-087248.json","markdown":"https://secwatch.observer/filing/0001104659-23-087248.md","text":"https://secwatch.observer/filing/0001104659-23-087248.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1035354/000110465923087248/0001104659-23-087248-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1035354/000110465923087248/tm2322789d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-12T06:58:43.284749+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}